Cite
HARVARD Citation
Thomas, M. et al. (n.d.). 8PSAFETY OF IMPRIME PGG, A NOVEL INNATE IMMUNE MODULATOR, IN ADULTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC). Annals of oncology. pp. vi3-vi4. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thomas, M. et al. (n.d.). 8PSAFETY OF IMPRIME PGG, A NOVEL INNATE IMMUNE MODULATOR, IN ADULTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC). Annals of oncology. pp. vi3-vi4. [Online].